C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2006
12/13/2006	CN1289682C Expression of genes in modified vaccinia virus ankara by using the cowpox ATI promoter
12/13/2006	CN1289671C Antibody molecules having specificity for human tumor necrosis factory alpha, and use thereof
12/13/2006	CN1289670C Polynucleotide useful for modulating cancer cell proliferation
12/13/2006	CN1289668C In vitro molecular directed evolution method for reshaping antibody
12/13/2006	CN1289526C Stem cell factor
12/13/2006	CN1289073C Hair growth stimulant
12/12/2006	US7148404 Antimicrobial polypeptides
12/12/2006	US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors
12/12/2006	US7148332 High affinity monoclonal antibody for recognizing the estrogen receptor (ER) and method for creating the antibody
12/12/2006	US7148326 Tumor antigen
12/12/2006	US7148323 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148201 Use of human plasma hyaluronidase in cancer treatment
12/12/2006	US7148063 Mitochondrial creatine kinase antibody
12/12/2006	US7148053 Transgenic yeast cells coding membrane receptor proteins for diagnosis and treatment of pancreatitis, pancreatic cancer, gastrointestinal disorders and irritable bowel disease
12/12/2006	US7148041 Animal product free media and processes for obtaining a botulinum toxin
12/12/2006	US7148040 Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface
12/12/2006	US7148039 Protein derived composition for skin care using spider silk protein or an analog with adjuvants
12/12/2006	US7148038 Immunotherapy; antiproliferative agent
12/12/2006	US7148037 Platelet-derived growth factor D, DNA coding therefor, and uses thereof
12/12/2006	US7148036 DNA molecules encoding cartilage-derived morphogenetic proteins
12/12/2006	US7148035 Polypeptide
12/12/2006	US7148034 Preparing bioactive peptides for the treatment of hypertension and/or enhancing food flavors
12/12/2006	US7148028 For diagnosis, prognosis, prophylaxis
12/12/2006	US7148026 Comprises g-protein coupled receptor polypeptide, melanin-concentrating hormone receptor (MCH) for treating hypertension, diabetes, cancer, dyslipidemias, cardiovascular disease, gall stones and osteoarthritis
12/12/2006	US7148019 Treating grass pollen allergen by administering a genetic engineered or synthetic protein or polypeptide; antiallergens
12/12/2006	US7148014 Methods of inhibiting phagocytosis
12/12/2006	US7148002 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
12/12/2006	US7147871 Submucosa gel compositions
12/12/2006	US7147861 Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate
12/12/2006	US7147858 Methods to improve immunogenicity of antigens and specificity of antibodies
12/12/2006	US7147855 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
12/12/2006	US7147853 Nucleotide sequences codin polypeptide for use in the treatment and prevention of cell proliferative and tumor disorders
12/12/2006	US7147851 Humanized immunoglobulin reactive with α4β7 integrin
12/12/2006	CA2189659C Production of biologically active recombinant neurotrophic protein
12/12/2006	CA2167080C Prrsv recombinant proteins, diagnostic kits and vaccines containing prrs recombinant proteins
12/12/2006	CA2159907C A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c
12/07/2006	WO2006129849A1 Anti-cd14 antibody-fused protein
12/07/2006	WO2006129835A1 METHOD FOR PRODUCING POLY-gamma-GLUTAMIC ACID AND MICROORGANISM USED IN THE PRODUCTION METHOD
12/07/2006	WO2006129751A1 High-copy-number, high-expression vector having methionine aminopeptidase gene therein
12/07/2006	WO2006128908A1 Production of recombinant il-18 binding protein
12/07/2006	WO2006103494A3 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
12/07/2006	WO2006065981A3 Nucleic acid molecules for optimized cab-2 expression and their use
12/07/2006	WO2006041849A3 Methods and compositions for concentrating secreted recombinant protein
12/07/2006	WO2005007803A3 Selection free growth of host cells containing multiple integrating vectors
12/07/2006	WO2003029401A8 Peptidoglycan recognition protein encoding nucleic acids and methods of use thereof
12/07/2006	US20060277626 Plant farnesyltransferases
12/07/2006	US20060277617 Nucleic acid construct, metabolic disordered non-human animal and use thereof
12/07/2006	US20060277614 Mammal prolactin variants
12/07/2006	US20060277613 Triple or double fusion vector harboring a Positron Emission Tomographic (PET), a bioluminescence and a fluorescence reporter gene that is imageable in living cells using a fluorescence microscope, a charge couple camera
12/07/2006	US20060276637 Antibodies
12/07/2006	US20060276633 Method for the mass production of immunoglobulin constant region
12/07/2006	US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins
12/07/2006	US20060276420 Generating cells for cell replacement therapy
12/07/2006	US20060276396 Stimulating insulin synthesis and release, enhancing adipose, muscle or liver tissue sensitivity towards insulin uptake, stimulating glucose uptake, slowing digestive process, or blocking the secretion of glucagon; glucagon-like protein
12/07/2006	US20060276383 Full length polynucleotide coding chicken type II collagen and the use of it
12/07/2006	US20060276377 Factor VII or VIIa Polypeptide Variants
12/07/2006	US20060276375 Gpi anchored glycoprotein aca as a novel tumor marker
12/07/2006	US20060275884 For reducing unwanted proteolysis during purification of a target protein; for improving protein folding, solubility, and stability when the protein is produced in vivo and in vitro
12/07/2006	US20060275878 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor
12/07/2006	US20060275876 Use of selective labeling to detect and characterize molecular interactions by nuclear magnetic resonance spectroscopy
12/07/2006	US20060275875 Thermostability; glucan synthesizing reaction is possible at high temperature conditions (60 degrees C. or higher)
12/07/2006	US20060275872 Method for modifying transglutaminases from microorganisms
12/07/2006	US20060275871 encoding mammalian Ca2+/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs); drug screening to identify compounds which modulate the enzymatic activity of expression products
12/07/2006	US20060275870 Novel G-protein coupled receptors and uses therefor
12/07/2006	US20060275869 Novel matrix metalloproteinases
12/07/2006	US20060275868 Fusion proteins comprising tumor necrosis factor receptor
12/07/2006	US20060275867 Process
12/07/2006	US20060275866 Novel nucleic acid sequences encoding G-protein coupled receptors
12/07/2006	US20060275865 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
12/07/2006	US20060275862 Saponin-decomposing enzyme, gene thereof and large-scale production system for producing soyasapogenol B
12/07/2006	US20060275838 Compositions and methods for inhibiting liver stellate cell growth
12/07/2006	US20060275831 Complement C3 precursor biopolymer markers predictive of type II diabetes
12/07/2006	US20060275827 non-oligomerizing Clavularia teal fluorescent protein (TFP) variant having a tyrosine-derived chromophore; nucleic acid compatible with mammalian codon usage
12/07/2006	US20060275823 Selection of peptides with antibody-like properties
12/07/2006	US20060275822 Fluorescent indicator using fret
12/07/2006	US20060275819 Guanylate-binding protein
12/07/2006	US20060275804 Enzymes having dehalogenase activity and methods of use thereof
12/07/2006	US20060275803 Rat and mouse members of the CRISP family of genes
12/07/2006	US20060275802 Mutations in OAS1 genes
12/07/2006	US20060275790 KCNQ5, a novel potassium channel
12/07/2006	US20060275767 Kinase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases and nucleotide sequences encoding such kinase sequences
12/07/2006	US20060275765 G-proteins
12/07/2006	US20060275764 Method for determining predisposition to manifestation of immune system related diseases
12/07/2006	US20060275755 Novel nucleic acids and polypeptides related to a guanine exchange factor of rho gtpase
12/07/2006	US20060275318 Surface protein of leptospira
12/07/2006	US20060275315 Nucleic acids and proteins from streptococcus groups a & b
12/07/2006	US20060275313 Therapeutic and diagnostic agents
12/07/2006	US20060275312 Molecule
12/07/2006	US20060275309 Peptide oligomers for use as hiv vaccines
12/07/2006	US20060275307 Antibodies to treat cancer
12/07/2006	US20060275304 Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/07/2006	US20060275302 a novel DNA, a carcinoma-associated gene comprising the DNA, a recombinant protein encoded by the DNA, an antibody binding to the protein, an anti-carcinoma agent comprising the antibody, a low-molecular-weight compound binding to the protein, a screening system
12/07/2006	US20060275301 Cell death-inducing agent
12/07/2006	US20060275292 Fully human anti-CD3 monoclonal antibodies
12/07/2006	US20060275287 Scroll compressor
12/07/2006	US20060275286 Monoclonal antibody named KIS-1N produced by the hybridoma cell line; for development of an agent for the diagnosis and prevention/treatment of diseases (cancer, and so forth) associated with the polypeptide
12/07/2006	US20060275283 Fcgamma receptor-binding polypeptide variants and methods related thereto
12/07/2006	US20060275280 Contacting a latent myostatin complex comprising a myostatin pro peptide and a myostatin C-terminal fragment, and a metalloprotease that can cleave the myostatin pro peptide, with an agent that increases or decreases proteolytic cleavage of the pro peptide by the metalloprotease
12/07/2006	US20060275264 Using an adeno-associated viral vector to deliver a nucleotide sequence encoding a novel glutamic acid decarboxylase (GAD) to specific regions of the brain that are over stimulated or disinhibited; neurodegenerative diseases, Alzheimer's and Parkinson's disease; antiepileptic agents; drug delivery

1 ... 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 ... 1125